Kymera Therapeutics Inc (KYMR)
Healthcare
Biotechnology
100.30 $
-3.0%
vs. previous close
Closing price · As of: 3. Aug 2026
Kymera Therapeutics Inc (KYMR) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -233 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| -18 | 18 | 88 | -129 | -153 | -103 | -195 | -233 | |
| 0.2 | 0.8 | 1.8 | 2.4 | 3.0 | 3.6 | 7.4 | 8.3 | |
| 0.6 | 1.2 | 5.2 | 25 | 35 | 43 | 55 | 60 | |
| 1.1 | 1.6 | 7.1 | 25 | 35 | – | – | – | |
| 2.3 | 2.8 | 125 | -62 | -38 | 9.3 | -24 | 15 | |
| 1.4 | 0.5 | 9.1 | 1.6 | 2.8 | 34 | 13 | 1.4 | |
| -1.4 | -16 | -423 | -100 | 21 | 140 | -404 | -521 | |
| – | – | 276 | 8.0 | 4.3 | – | – | – | |
| -0.3 | -0.4 | -0.6 | -0.8 | -1.1 | -0.1 | -1.6 | -1.5 | |
| 53 | 35 | 289 | 250 | 153 | 4.2 | 609 | 991 | |
| 34 | 36 | -45 | 21 | 20 | 41 | 10 | 237 | |
| -19 | 17 | 79 | -131 | -156 | -137 | -207 | -234 |
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.